CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands |
Total |
Common Stock |
Additional Paid-In Capital |
Accumulated Other Comprehensive Income (Loss) |
Accumulated Deficit |
| Beginning Balance, Shares at Dec. 31, 2024 |
|
68,629,738
|
|
|
|
| Beginning Balance at Dec. 31, 2024 |
$ 164,765
|
$ 7
|
$ 771,542
|
$ (92)
|
$ (606,692)
|
| Issuance of common stock upon financing, net of issuance costs, Shares |
|
19,714,285
|
|
|
|
| Issuance of common stock upon financing, net of issuance costs |
65,577
|
$ 2
|
65,575
|
|
|
| Issuance of common stock upon exercise of stock options, Shares |
|
36,310
|
|
|
|
| Issuance of common stock upon exercise of stock options |
57
|
|
57
|
|
|
| Issuance of common stock upon vesting of RSUs |
|
700,488
|
|
|
|
| Stock-based compensation expense |
6,833
|
|
6,833
|
|
|
| Other comprehensive income (loss) |
92
|
|
|
92
|
|
| Net loss |
(35,907)
|
|
|
|
(35,907)
|
| Ending Balance, Shares at Mar. 31, 2025 |
|
89,080,821
|
|
|
|
| Ending Balance at Mar. 31, 2025 |
201,417
|
$ 9
|
844,007
|
|
(642,599)
|
| Beginning Balance, Shares at Dec. 31, 2024 |
|
68,629,738
|
|
|
|
| Beginning Balance at Dec. 31, 2024 |
164,765
|
$ 7
|
771,542
|
(92)
|
(606,692)
|
| Net loss |
(111,736)
|
|
|
|
|
| Ending Balance, Shares at Sep. 30, 2025 |
|
109,766,382
|
|
|
|
| Ending Balance at Sep. 30, 2025 |
331,996
|
$ 11
|
1,049,598
|
815
|
(718,428)
|
| Beginning Balance, Shares at Mar. 31, 2025 |
|
89,080,821
|
|
|
|
| Beginning Balance at Mar. 31, 2025 |
201,417
|
$ 9
|
844,007
|
|
(642,599)
|
| Issuance of common stock upon exercise of stock options, Shares |
|
855
|
|
|
|
| Issuance of common stock upon exercise of stock options |
2
|
|
2
|
|
|
| Issuance of common stock upon vesting of RSUs |
|
74,674
|
|
|
|
| Stock-based compensation expense |
7,350
|
|
7,350
|
|
|
| Other comprehensive income (loss) |
551
|
|
|
551
|
|
| Net loss |
(41,443)
|
|
|
|
(41,443)
|
| Ending Balance, Shares at Jun. 30, 2025 |
|
89,156,350
|
|
|
|
| Ending Balance at Jun. 30, 2025 |
167,877
|
$ 9
|
851,359
|
551
|
(684,042)
|
| Issuance of common stock upon financing, net of issuance costs, Shares |
|
20,125,000
|
|
|
|
| Issuance of common stock upon financing, net of issuance costs |
190,737
|
$ 2
|
190,735
|
|
|
| Issuance of common stock upon exercise of stock options, Shares |
|
95,787
|
|
|
|
| Issuance of common stock upon exercise of stock options |
428
|
|
428
|
|
|
| Issuance of common stock upon vesting of RSUs |
|
389,245
|
|
|
|
| Stock-based compensation expense |
7,076
|
|
7,076
|
|
|
| Other comprehensive income (loss) |
264
|
|
|
264
|
|
| Net loss |
(34,386)
|
|
|
|
(34,386)
|
| Ending Balance, Shares at Sep. 30, 2025 |
|
109,766,382
|
|
|
|
| Ending Balance at Sep. 30, 2025 |
$ 331,996
|
$ 11
|
1,049,598
|
815
|
(718,428)
|
| Beginning Balance, Shares at Dec. 31, 2025 |
109,884,502
|
109,884,502
|
|
|
|
| Beginning Balance at Dec. 31, 2025 |
$ 305,259
|
$ 11
|
1,056,271
|
404
|
(751,427)
|
| Issuance of common stock upon exercise of stock options, Shares |
|
465,661
|
|
|
|
| Issuance of common stock upon exercise of stock options |
3,230
|
|
3,230
|
|
|
| Issuance of common stock upon vesting of RSUs |
|
676,314
|
|
|
|
| Stock-based compensation expense |
6,120
|
|
6,120
|
|
|
| Other comprehensive income (loss) |
(164)
|
|
|
(164)
|
|
| Net loss |
(41,284)
|
|
|
|
(41,284)
|
| Ending Balance, Shares at Mar. 31, 2026 |
|
111,026,477
|
|
|
|
| Ending Balance at Mar. 31, 2026 |
$ 273,161
|
$ 11
|
1,065,621
|
240
|
(792,711)
|
| Beginning Balance, Shares at Dec. 31, 2025 |
109,884,502
|
109,884,502
|
|
|
|
| Beginning Balance at Dec. 31, 2025 |
$ 305,259
|
$ 11
|
1,056,271
|
404
|
(751,427)
|
| Issuance of common stock upon exercise of stock options, Shares |
1,241,847
|
|
|
|
|
| Net loss |
$ (130,196)
|
|
|
|
|
| Ending Balance, Shares at Sep. 30, 2026 |
128,544,202
|
128,544,202
|
|
|
|
| Ending Balance at Sep. 30, 2026 |
$ 753,736
|
$ 13
|
1,635,525
|
(179)
|
(881,623)
|
| Beginning Balance, Shares at Mar. 31, 2026 |
|
111,026,477
|
|
|
|
| Beginning Balance at Mar. 31, 2026 |
273,161
|
$ 11
|
1,065,621
|
240
|
(792,711)
|
| Issuance of common stock upon exercise of stock options, Shares |
|
256,272
|
|
|
|
| Issuance of common stock upon exercise of stock options |
1,332
|
|
1,332
|
|
|
| Issuance of common stock upon vesting of RSUs |
|
85,534
|
|
|
|
| Stock-based compensation expense |
8,318
|
|
8,318
|
|
|
| Other comprehensive income (loss) |
(221)
|
|
|
(221)
|
|
| Net loss |
(43,423)
|
|
|
|
(43,423)
|
| Ending Balance, Shares at Jun. 30, 2026 |
|
111,368,283
|
|
|
|
| Ending Balance at Jun. 30, 2026 |
239,167
|
$ 11
|
1,075,271
|
19
|
(836,134)
|
| Issuance of common stock upon financing, net of issuance costs, Shares |
|
16,203,500
|
|
|
|
| Issuance of common stock upon financing, net of issuance costs |
544,569
|
$ 2
|
544,567
|
|
|
| Issuance of common stock upon exercise of stock options, Shares |
|
519,914
|
|
|
|
| Issuance of common stock upon exercise of stock options |
5,316
|
|
5,316
|
|
|
| Issuance of common stock upon vesting of RSUs and PSUs |
|
452,505
|
|
|
|
| Stock-based compensation expense |
|
|
10,371
|
|
|
| Other comprehensive income (loss) |
(198)
|
|
|
(198)
|
|
| Net loss |
$ (45,489)
|
|
|
|
(45,489)
|
| Ending Balance, Shares at Sep. 30, 2026 |
128,544,202
|
128,544,202
|
|
|
|
| Ending Balance at Sep. 30, 2026 |
$ 753,736
|
$ 13
|
$ 1,635,525
|
$ (179)
|
$ (881,623)
|